AzTrials
AzTrials

Revision ArthroplastyWESNCT07836608

Watson Extraction System for Femoral Stem Extraction

A study testing Watson Extraction System in people with Revision Arthroplasty, run by Ottawa Hospital Research Institute at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

A revision total hip replacement surgery requires the surgeon to remove, or extract, the femoral stem (the rod that was placed into the thigh bone during your first hip replacement). A variety of tools and techniques can be used to do this. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Revision Arthroplasty
What is being tested?
Watson Extraction System
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
1 Oct 2026to 1 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Over 18 years of age
  • Undergoing revision Total Hip Arthroplasty for septic or aseptic indications
  • Have well-fixed femoral components, of blade-stem design (collared and collarless)

Who cannot join

  • Tapered stem in situ less than 4 months
  • Cemented Stems
  • Femoral Stems with Trunnions > 14mm
  • Femoral Stems of alternative design not compatible for use with the WES

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Clinical Research Coordinator contact

613-737-8899 ext. 73032

meadufresne@ohri.ca

Canada1 site
  • The Ottawa Hospital

    Ottawa, Ontario, K1H 8L6

    Clinical Research Coordinator, 613-737-8899 ext. 73032, meadufresne@ohri.ca

Other trials in Canada

About this study

Official title: Is Use of the Watson Extraction System Associated With Reduced Operative Time and Safer Stem Extraction? - A Randomized Controlled Trial

A revision total hip replacement surgery requires the surgeon to remove, or extract, the femoral stem (the rod that was placed into the thigh bone during your first hip replacement). A variety of tools and techniques can be used to do this. At The Ottawa Hospital (TOH) surgeons attempt to remove the stem using less invasive measures, such as osteotomes, a tool that separates the stem from the bone, but if it doesn't work, they may need to perform an extended trochanteric osteotomy (ETO). An ETO is more invasive and increases the risk of complications.

The Watson Extraction System (WES) is another Health Canada approved tool that goes around the stem to help remove the femoral stem from the thigh bone. Research shows that the WES has been studied in case series of a few people, and the results seem promising, reducing the time of extraction and need for ETO. However, it is not clear if it offers better results than what is currently done at TOH.

The purpose of this study is to compare the WES to the current/usual care care at TOH to determine whether the WES can remove the femoral stem more efficiently (in less time and at a lower hospital cost) and effectively, while improving patient safety.

Being tested
Watson Extraction System, Standard of Care Stem Extraction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Watson Extraction SystemDevice

    The Watson Extraction System is a surgical instrumentation system used to facilitate femoral stem extraction during revision total hip arthroplasty. Participants randomized to the intervention group will undergo femoral stem extraction using the Watson Extraction System.

  • Standard of Care Stem ExtractionProcedure or surgery

    Femoral stem extraction will occur using standard surgical techniques and instrumentation routinely available for revision total hip arthroplasty.

Study groups in NCT07836608
Study groupRoleWhat they receive
Watson Extraction System (WES)ExperimentalParticipants randomized to this arm will undergo stem extraction utilizing the WES in addition to other standard of care equipment, as required. Surgeons will use the WES device for extraction first.
Receives: Device: Watson Extraction System
Current Standard of Care at TOHActive comparatorParticipants randomized to this arm will undergo stem extraction as per surgeon preference with the use of K-wires, burr and flexible osteotomes. An ETO will be performed as per surgical judgement.
Receives: Procedure: Standard of Care Stem Extraction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timing of surgery

    The time it take to complete the surgery, including the femoral stem extraction

    Measured: From surgery start to surgery close

  2. Time of Femoral Stem Extraction

    Amount of time, in minutes, it takes to remove the femoral stem during surgery

    Measured: From start of femoral stem extraction to end of femoral stem extraction, up to 60 minutes

Secondary outcomes (6)
  1. Intraoperative complication rate

    Proportion of participants experiencing an intraoperative complication related to femoral stem extraction, including femoral fracture, cortical perforation, or extended trochanteric osteotomy use.

    Measured: From surgery start to surgery close

  2. Postoperative Complication Rate

    Proportion of participants experiencing a postoperative complication or require a reoperation relating to the hip revision.

    Measured: From end of surgery to 3 months postoperative

  3. Change in Patient-report Hip function from baseline to 3 months

    Participants will complete the Oxford Hip Score to assess hip function, where 0 is worse possible hip function and 48 is best hip function.

    Measured: Baseline and at 3 month following surgery

  4. Change in Health Related Quality of Life from Baseline to 3 months

    Participants will complete the EQ-5D-5L to assess health related quality of life, where an index scores range from -0.573 to 1.00, with higher scores indicating better health related quality of life.

    Measured: At baseline and 3 months after surgery

  5. Cost of OR time and resources

    Unit costs of OR time and resources, as per institutional financial data and standard costing sources.

    Measured: From start of surgery to end of surgery

  6. Cost of complications

    Unit cost of complications derived from institutional financial data and standard costing sources

    Measured: From end of surgery to 3 months postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Sep 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07836608
Sponsor's protocol ID
20260480-01H
Acronym
WES
Status last verified
Sep 2026
First submitted
26 Aug 2026
Last updated
29 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Watson Extraction System in people with Revision Arthroplasty, run by Ottawa Hospital Research Institute at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Clinical Research Coordinator (613-737-8899 ext. 73032, meadufresne@ohri.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timing of surgery (time frame: From surgery start to surgery close). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in